As far as healthcare goes, Boston has historically focused on biotechnology, life sciences, and pharmaceuticals. Until a few years ago, digital health wasn’t a big talking point in the Boston healthcare scene. After a multilateral initiative launched in 2016, however, Boston wants to be regarded as a national leader in digital healthcare investment and activity.
With a focus on improving health, driving economic growth, and expanding the country’s research capacity, the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services is the largest public funder of biomedical research in the world. Because of NIH’s central role in supporting science, technology, and innovation, a better understanding of the agency’s footprint may be helpful to the technology-based economic development practitioner community. This edition of Useful Stats utilizes data from NIH’s Research Portfolio Online Reporting Tool (RePORT) and covers each year from 2007 to 2016. The data does not include projects funded by the American Recovery and Reinvestment Act of 2009.
Tuesday, September 26, 2017 9:00AM-5:00PM
Women of the Virginia bioscience community from across the state will lead this full day event offering examples of working together to build a stronger bioscience industry, stronger companies and institutions, stronger teams and networks, and stronger individuals.
New this year, we’re co-locating our event with The MedTech Conference powered by AdvaMed, to San Jose, CA!
Join us for this important program that dives into the changing landscape and the issues facing our pathway to greater innovation. This year’s theme is “Partnering for Breakthroughs in Pediatric Surgery and Care.”
Albeit small, Baltimore’s startup community is a thriving one. Just 45 minutes outside of the District, the city’s innovation scene is rich with opportunity and talent.
Maybe that’s why Baltimore is one of the most successful places working with Venture for America, a two-year salaried fellowship program that matches recent college grads with startups in 18 different cities.
Over the past year, Johns Hopkins University has played an integral role in bringing a nationwide program designed to boost small businesses to Baltimore and helping it flourish.
Today, program partners Goldman Sachs and Bloomberg Philanthropies announced a five-year, $10 million commitment to continue the program in Baltimore and named JHU the host site.
As Inova Health System prepares to open its new personalized health accelerator this fall, startups recently learned the terms of winning a spot there.
Inova plans to offer $75,000 in funding in exchange for 10 percent equity in early-stage companies selected to join the accelerator, Managing Director Hooks Johnston told an audience at a D.C. event last week. Johnston went on to say, according to Technical.ly DC, companies that make it through an individualized program for four or five months and can get $250,000 in third-party commitments can receive an Inova match.
Scientists for the first time have successfully edited genes in human embryos to repair a common and serious disease-causing mutation, producing apparently healthy embryos, according to a study published on Wednesday.
Tue, December 12, 20174:30 PM – 8:00 PM EST
Join more than 400 of the region’s business, government and community leaders for the Economic Alliance of Greater Baltimore’s Annual Meeting, December 12, 2017 at M&T Bank Stadium. As we celebrate our 20th Anniversary, we will take a look back at the success and growth that the region has experienced over the last two decades, while also featuring Greater Baltimore’s future as a global leader. As we celebrate the results of longstanding partnerships that have led to Baltimore’s economic success, we look forward to celebrating the visionaries and leaders who will shape our tomorrow.
The Precision Medicine Policy and Ethics Conference is a forum for national and industry leaders to address the most pressing challenges in the clinical adoption and integration of genomic medicine. The discussion will take place before an audience of providers, policymakers, scientists and academics. Programming for the conference will examine the ethical and regulatory issues surrounding this topic, including integrating precision medicine into physician education and practice, demographic and socioeconomic barriers to widespread access, and the role and rights of patients concerning genetic data.
